Treatment Information

Back

Prostate Cancer treatment details. Chemotherapy, Hormone.

University of Texas Health Science Center at Houston, Houston, TX, United States.

Survival: monthsCountry:United States
Toxiciy Grade:4City/State/Province:Houston, TX
Treatments:Chemotherapy, HormoneHospital:University of Texas Health Science Center at Houston
Drugs:Journal:Link
Date:Jun 2013

Description:

Patients:
This phase 2 study involved 45 advanced prostate cancer patients with a median patient age of 65 years.

Treatment:
Patients were treated with androgen deprivation therapy and chemotherapy with doxorubicin, ketoconazole, docetaxel, and estramustine.

Toxicities:
The most severe toxicities were of grade 4 and included pneumonia, stroke, and neutropenia. Grade 3 increased blood pressure and infection were also reported.

Results:
The median overall survival was 53.7 months.

Correspondence: Dr. Robert Amato; email: robert.amato@uth.tmc.edu



Back